The Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion

Similar documents
E-Cigarette Vaping: The Good, the Bad and the Ugly

PROJECT NEWS. Youth and Young Adult Vaping in Canada. Background. Methods. Key Findings

OCSA HEALTH CANADA NOTICE OF INTENT - Vape Products

Melodie Tilson, Director of Policy

OMA Submission on Health Canada s Proposed Regulations for Additional Cannabis Products. February 2019

MARKETING STANDARDS FOR MEMBERSHIP

How to Regulate E-Cigarettes? Are we asking the right questions?

The New Zealand experience with electronic cigarettes

Cannabis Legalization August 22, Ministry of Attorney General Ministry of Finance

Electronic cigarettes: A new era for tobacco harm reduction Adapted for SW Specialist Nurses for Children in Care meeting 17 January 2017

Discussion points on Bill S-5

Electronic Nicotine and Non Nicotine Delivery Systems (ENDS)

REDUCING YOUTH ACCESS AND APPEAL OF VAPING PRODUCTS CONSULTATION ON POTENTIAL REGULATORY MEASURES

Who is Targeting You? The Tobacco Industry Those who want to profit from your smoking

ESPs are battery-operated devices that contain cartridges filled with liquid chemicals. The chemicals turn into a vapour that the user inhales (this

The Latest on Vaping Among U.S. Teens

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

City of Oshawa Comments to the Provincial Government Concerning Cannabis Consumption

Bill. amending the Tobacco Control Act, No. 6/2002, with subsequent amendments. From the Minister of Health.

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

Cannabis Legalization

Marijuana Legalization Public Health Considerations & Municipal Options

Prof Linda Bauld 1,2,3, Kathryn Angus 1,3, Dr Marisa de Andrade 3,4, Dr Allison Ford 1,2,3

AMA Submission House of Representatives Standing Committee on Health and Ageing inquiry into the

Healthy People, Healthy Communities

EXECUTIVE SUMMARY. 1 P age

ELECTRONIC NICOTINE DELIVERY DEVICES

Wayne Hall and Coral Gartner University of Queensland

Why comprehensive TC is essential for successful harm reduction

burden of tobacco Key Findings about the Use and Consequences of Tobacco in Peel

Key Elements of this Presentation. Smoking Still Main Cause of Premature Death 31/10/2013. The Case for Plain Packaging

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT

WHAT IS NO BUTTS ABOUT IT?

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)

Cannabis Legalization and Regulation in British Columbia Discussion Paper

RNAO response to proposed regulation under Smoke-Free Ontario Act, 2017

Guideline for Advertising of e-cigarettes

PA Consultation Document: Cannabis

Advancing the Tobacco Endgame: Evidence and Progress. alpha Board Meeting April 24 th, 2015 Robert Schwartz

E-cigarette reforms. Supplement to the Tobacco retailer guide about reforms commencing 1 August 2017

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

Flavors Hook Kids. The Tobacco Industry s Kids Menu MARIPOSA COUNTY HEALTH DEPARTMENT

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

Smoking Cessation: A readily modifiable risk factor

UPDATES FROM THE FDA CENTER FOR TOBACCO PRODUCTS (CTP)

Evaluating Interventions to Curb ENDS Use Among Utah Youth

Cigarette Packaging in Ireland: The Plain Future.

Addition of Edibles and Other Products to Federal Cannabis Legislation

15 Electronic Cigarettes Update

Marketing a healthier choice: Exploring young people s perception of e-cigarettes

DRAFT FOR CONSULTATION

Tobacco-Control Policy Workshop:

THE IMPORTANCE OF POINT OF SALE

Monitoring and Evaluating Ontario s New Tobacco Policy Measures: Flavoured Tobacco Prohibition

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

SIPP Phase II: Vaping and Vapor Devices. Subcommittee Briefing and Discussion

British American Tobacco Snus Marketing Standards

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

consistent with the industry documents we note in our September letter.

Guidelines for Registration as a Tobacconist

Problem Which option Additional option Additional comments definition Yes No change No further observations.

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

ACS Submission: Consultation on the advertising of electronic cigarettes

YOUR GUIDE TO TOBACCO LEGISLATION

Message From the Minister

Tobacco Control Policy and Legislation Antero Heloma, MD, PhD Principal Medical Adviser. 20/03/2012 Presentation name / Author 1

Frequently Asked Questions

Legalization of Cannabis- Overview

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

Policy Options for the Regulation of Electronic Cigarettes

TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES MICHIGAN CANCER CONSORTIUM MARCH 26, 2014

Ryan Smith, Community Planning Department Manager

Global Adult Tobacco Survey TURKEY. Dr. Peyman ALTAN MoH Tobacco Control Dep. Ankara November 2018

BIG TOBACCO TINY TARGETS

Competition in the Vaporized Nicotine Market and its Potential Impact on the Cigarette Market. David T. Levy Georgetown University

Office of the Chief Medical Health Officer

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

SUBJECT: Cannabis legislation and implications for the City of Burlington

PLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.

Health First: an alternative alcohol strategy for the UK. Linda Bauld

Tobacco Packages: Ads for tobacco companies or tools for public health?

CMA Submission: Submission to the Senate Standing Committee on Social Affairs, Science and Technology

To view an archived recording of this presentation please click the following link: Please scroll down this

SMOKE - FREE ONTARIO. The Next Chapter For a Healthier Ontario

Tobacco Control. (Update 2008)

Tobacco 21 in Oregon 7,000. Leading Causes of Preventable Death in Oregon. Most addiction to tobacco starts in adolescence.

STANDARDISED PACKAGING AND TOBACCO PRODUCTS DIRECTIVE

Cannabis Retail Store Licensing in Ontario. General Committee December 10, 2018

Ontario Medical Association. Recommendations to the Ministry of the Attorney General on Recreational Cannabis Consultation

The plain truth: Australia s world first plain packaging legislation

TIPS THINK CRITICALLY:

PLANNING IMPLICATIONS FOR CANNABIS LEGISLATION. Zone 7 & 8 Spring Workshop April 19, 2018

Policy Options for the Regulation of Electronic Cigarettes

AA Response: CAP consultation on the advertising of electronic cigarettes

Tobacco Surveillance and Evaluation: An Update

JUUL and Other Emerging Tobacco Products. Emily McClelland, M.S. December 6, 2018

Strengthening Ontario s Smoking and Vaping Laws Summary of Proposed Regulation under Smoke-Free Ontario Act, 2017

RESPONSE FROM ALTRIA:

UPDATED: Alberta's Cannabis Retail Regulations and City of Calgary Land Use Bylaw Amendments

Transcription:

The Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion Background: E-Cigarette Point-of-Sale Promotion September 2018 Key Message: Vaping e-cigarettes can lead to dependence, long-term regular use and serious health effects. In spite of the Act, e-cigarettes are being promoted and marketed to young nonsmokers. A growing number of studies over the last few years have investigated vape shop staff perspectives on vaping, particularly regarding the effectiveness of vaping as a smoking cessation strategy. These perspectives are of great relevance to researchers and policy-makers, as vape shop staff beliefs, attitudes and behaviours related to vaping likely influence the messages communicated to customers at point of sale. Information from vape shop staff has been found to be mostly gathered through personal experience or customer experiences, with minimal reported verification of this information. 1 For example, personal experiences of vape shop staff who successfully quit smoking by vaping may influence the advice provided to customers looking to quit smoking, despite the limited evidence of the efficacy of vaping as a cessation strategy. Indeed, many vape shop staff have reported successfully quitting smoking by vaping, and express personal conviction their stories of quitting can help their customers who are trying to quit. 2 This narrative approach to vaping product promotion, often used in vape shops, has been found to be persuasive and to reduce resistance to messaging in the health communication literature. 2 Moreover, vape shop staff consistently reported mostly positive views on the health effects of vaping, despite the lack of evidence on the health consequences of its long term use. In one study, 24% of retailers thought that e-cigarettes were completely safe. 3 Retailers may overestimate the benefits, and underestimate potential risks, of e-cigarettes when discussing Ontario Tobacco Research Unit 1

them with customers. 3 This discrepancy may be amplified by the emotional investment that some vape shop staff may have in these products, given their personal success in quitting smoking by using vaping products, leading them to have more positive views on the health effects of vaping. Consequently, messages being communicated to vape shop customers at point-of-sale, while likely well-intentioned, may contain misinformation. Research on Electronic Cigarettes and Waterpipe (RECIG-WP) Point-of-Sale Study OTRU is conducting research on e-cigarettes and waterpipe to advance knowledge and understanding of product availability and marketing, trends in product use and co-use. One of the current initiatives under RECIG-WP is a point-of-sale study, which collected data on e- cigarette and waterpipe product availability and marketing at 50 retail stores. Observations and interviews took place in five different cities: Toronto, Sudbury, Ottawa, Hamilton and London. We targeted 10 in-store observations in each of these cities, including: 5 vape shops, 3 convenience stores, 1 tobacconist, and 1 head shop. The Tobacco and Vaping Products Act Bill S-5, a federal Act to amend the Tobacco Act and Non-smokers Health Act and to make consequential amendments to other Acts, received Royal Assent on May 23, 2018. Part 1 of the Act amends the Tobacco Act to regulate the manufacture, sale, labelling and promotion of vaping products in Canada. Bill S-5 replaced the Tobacco Act (1997) with the Tobacco and Vaping Products Act. Many of the new federal rules will impact point-of-sale practices in the brick-and-mortar vape shops. How Will the Tobacco and Vaping Products Act Affect Point-of-Sale Promotion in Ontario? Point-of-Sale Promotion in Convenience Stores Presently, there are no provincial restrictions on the promotion of vaping products in Ontario. Since the Act was passed, vaping products have been aggressively marketed in convenience stores, including product displays, posters and placement of vaping products beside candy and Ontario Tobacco Research Unit 2

sweets. In particular, promotion of British American Tobacco s Vype brand e-cigarettes is evident in chain convenience stores, at gas pumps and now also advertised on TV. This type of marketing echoes strategies used by tobacco companies in the past. Vaping Products with Nicotine Can Be Legally Sold to Adults Before Bill S-5 received Royal Assent on May 23, 2018, it was illegal to sell e-cigarettes and e- liquids containing nicotine in Canada. Nevertheless, e-cigarette products with nicotine have been openly sold in vape shops, convenience stores and other venues. The Tobacco and Vaping Products Act introduces a regulatory framework that allows adults aged 18 years or older to legally purchase vaping products containing nicotine as a less harmful alternative to tobacco. Prior to the Tobacco and Vaping Products Act, the major transnational tobacco companies stayed out of Canada s vaping market. However, now they have actively started to promote their own e-cigarette brands and it is anticipated that there will be a major shift in the market. Similarly, JUUL brand e-cigarettes have entered the Canadian market now that it is legal to sell vaping products containing nicotine. JUUL and similar pod mods have very high nicotine concentrations one cartridge (about 200 puffs) contains as much nicotine as an entire pack of cigarettes. In the US, JUUL has quickly captured more than half of the e-cigarette market with its sleek, nicotine-packed product. Although the legislation bans sales to youth under the age of 18, lessons from minimum age stipulations for tobacco suggest that e-cigarettes containing nicotine will be easily available to young people. Since nicotine is highly addictive 4 and has been shown to affect brain development, 4 it will be important for the public health community to closely monitor the initiation and uptake of e-cigarettes by young people. No Testimonials or Endorsements Under the Tobacco and Vaping Products Act, no person shall promote a vaping product through a testimonial or an endorsement, however displayed or communicated, including by means of packaging. In our RECIG-WP point-of-sale study, vape shop employees told us that they often discuss their own experiences of quitting smoking through vaping with potential customers, a finding corroborated by other studies. 2 Our analysis of point-of-sale promotional Ontario Tobacco Research Unit 3

materials and of e-cigarette packaging including flavour names indicates that a substantial amount of vaping product promotion goes on in vape shops. Consequently, the prohibition of testimonials and endorsements outlined in the Tobacco and Vaping Products Act may require substantial changes in practices at vape shops. No False Promoting of Vaping Products Health Effects or Hazards One of the objectives of the Tobacco and Vaping Products Act is to prevent the public from being deceived or misled with respect to the health hazards of using vaping products. Rules will be stricter around making health claims related to vaping that are unsubstantiated by evidence. Many vape shop staff interviewed in the RECIG-WP point-of-sale study said that they would not recommend vaping to a customer who did not smoke, which may indicate that staff are aware that vaping is not harmless. To support vape shop staff with implementing this new rule, clear and accurate information on health effects or hazards should be made easily accessible from a reputable, non-biased source, such as Health Canada. No Promotion of Vaping Products Using Smoking as a Comparison The Tobacco and Vaping Products Act prohibits individuals from making comparisons between the health effects resulting from the use of vaping products with those resulting from the use of tobacco products. The RECIG-WP point-of-sale study consistently found the same key message in narratives about vaping from vape shop staff vaping is healthier than smoking. The prohibition of making comparisons between the health effects of using e-cigarettes or tobacco products may impact point-of-sale narratives that vaping is a legitimate harm reduction approach to smoking cessation. Literature shows that vape shop staff view themselves as public health advocates who believe in harm reduction. 2 Conclusion E-cigarettes are now being aggressively marketed at point-of-sale in convenience stores as well as in vape shops, with and without claims about health effects and about smoking cessation effectiveness. Our research suggests that e-cigarettes are being promoted in such a way as to attract youth and young adult nonsmokers and that vape shops serve as a major channel of the marketing and promotion of e-cigarettes for recreational purposes. Considering the addictive Ontario Tobacco Research Unit 4

properties of nicotine and the potential health effects of vaping, it will be important to study the effects of the Tobacco and Vaping Products Act on the use of e-cigarettes by nonsmokers. References 1 Tsai J, Bluthenthal R, Allem J-P, Garcia R, Garcia J, Unger J, Baezconde-Garbanati L, Sussman S. Vape shop retailers perceptions of their customers, products and services: A content analysis. Tobacco Prevention & Cessation 2017;2(Supplement). doi:10.18332/tpc/70345. 2 Hart J, Walker K, Sears C, Lee A, Smith C, Siu A, Keith R, Ridner S. Vape shop employees: Public health advocates? Tobacco Prevention & Cessation. 2017;2(Supplement). doi:10.18332/tpc/67800. 3 Allem J-P, Unger JB, Garcia R, Baezconde-Garbanati L, Sussman S. Tobacco attitudes and behaviors of vape shop retailers in Los Angeles. American Journal of Health Behavior. 2015;39(6):794-798. doi:10.5993/ajhb.39.6.7. 4 National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E- Cigarettes. Washington, DC: National Academies Press; 2018. Ontario Tobacco Research Unit 5